CELYAD ONCOLOGY (CYAD.BR) Stock Cash Flow
EBR:CYAD - Euronext Brussels - BE0974260896 - Common Stock - Currency: EUR
| TTM (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -7.75M | -8.45M | -40.88M | -26.51M | -17.20M | |||
| Depreciation Amortization | 626.00K | 794.00K | 1.44M | 1.52M | 1.83M | |||
| Change In Working Capital | -2.91M | -6.45M | -1.84M | 1.43M | -2.02M | |||
| Other non cash items | 336.00K | -1.10M | 13.27M | -3.08M | -10.28M | |||
| OPERATING CASH FLOW | -9.70M | -15.20M | -28.01M | -26.64M | -27.66M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -702.00K | -934.00K | -123.00K | -393.00K | -319.00K | |||
| Other Investing Activity | N/A | 1.34M | 7.33M | 267.00K | 476.00K | |||
| INVESTING CASH FLOW | -676.00K | 407.00K | 7.20M | -126.00K | 157.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -136.00K | -145.00K | -1.02M | -1.14M | -1.45M | |||
| Stock Issued/Repurchased | N/A | 9.49M | N/A | 36.57M | 0.00 | |||
| Other Financing Activity | 2.27M | 10.00K | 4.26M | 4.09M | 6.84M | |||
| FINANCING CASH FLOW | 11.63M | 9.36M | 3.24M | 39.52M | 5.40M | |||
| Exchange Rate Effect | 0.00 | -1.00K | -6.00K | 32.00K | 8.00K | |||
| CHANGE IN CASH | 1.25M | -5.44M | -17.57M | 12.78M | -22.10M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -9.70M | -15.20M | -28.01M | -26.64M | -27.66M | |||
| Capital Expenditure | -702.00K | -934.00K | -123.00K | -393.00K | -319.00K | |||
| FREE CASH FLOW | -10.40M | -16.14M | -28.13M | -27.04M | -27.98M | |||
All data in EUR